RB

Raziuddin Bashiruddin Shaikh

Director Director DIN 02055014
DIN 02055014 First appointment Feb 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2005
Shareholding value •••• Premium profile

About Raziuddin Bashiruddin Shaikh

Data last updated:

Raziuddin Bashiruddin Shaikh was a Director at Aegis Medicines Pvt Ltd (2005–2009) and Director at Apex Medichem Private Limited (2005–2013). The companies operate in Pharma.

DIN 02055014
Primary Designation Director
Industry Pharma
First Appointment 01 Feb 2005

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aegis Medicines Pvt Ltd U99999PN1993PTC073083
Director01 Feb 20051993Under Liquidation
Apex Medichem Private Limited U24230MH2005PTC152123
Director22 Mar 20052005₹30.17 Cr (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aegis Medicines Pvt Ltd
Apex Medichem Private Limited
Premium access

Shareholding and investment profile for Raziuddin Bashiruddin Shaikh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raziuddin Bashiruddin Shaikh

Raziuddin Bashiruddin Shaikh was first appointed on 01 Feb 2005 as Director at Aegis Medicines Pvt Ltd.

Raziuddin Bashiruddin Shaikh held 2 earlier board appointments: Aegis Medicines Pvt Ltd (Director, 01 Feb 2005 to 15 Jun 2009); Apex Medichem Private Limited (Director, 22 Mar 2005 to 05 Apr 2013).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available